Novartis AG (SWX:NOVN)
101.52
-0.46 (-0.45%)
Aug 28, 2025, 1:42 PM CET
Novartis AG Employees
Novartis AG had 75,883 employees as of December 31, 2024. The number of employees decreased by 174 or -0.23% compared to the previous year.
Employees
75,883
Change (1Y)
-174
Growth (1Y)
-0.23%
Revenue / Employee
578.37K CHF
Profits / Employee
143.10K CHF
Market Cap
197.42B
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 75,883 | -174 | -0.23% |
Dec 31, 2023 | 76,057 | -25,646 | -25.22% |
Dec 31, 2022 | 101,703 | -2,620 | -2.51% |
Dec 31, 2021 | 104,323 | -1,471 | -1.39% |
Dec 31, 2020 | 105,794 | 1,880 | 1.81% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
Company Name | Employees |
---|---|
Roche Holding AG | 103,249 |
Lonza Group AG | 18,944 |
Galderma Group AG | 6,545 |
Alcon | 25,599 |
Sandoz Group AG | 22,049 |
Straumann Holding AG | 11,815 |
Sonova Holding AG | 18,366 |
Ypsomed Holding AG | 2,644 |
Novartis AG News
- 22 hours ago - NHS to lose out on new drugs, pharma firm warns - BBC
- 1 day ago - Novartis and BioArctic sign collaboration and license deal - Seeking Alpha
- 2 days ago - BioArctic and Novartis sign an option, collaboration and license agreement using BrainTransporter™ for an upfront payment of USD 30 million plus additional potential milestones and royalties - PRNewsWire
- 8 days ago - Profits at Novartis Ireland down to 8.4m as firm raises research and development spend - Independent Ireland
- 10 days ago - New Novartis ESC data highlights strength of cardiovascular portfolio - GlobeNewsWire
- 15 days ago - Novartis Sees Hope In Reducing Lifelong Treatment Burden For Autoimmune Blood Disorder - Benzinga
- 16 days ago - Novartis ianalumab Phase III trial meets primary endpoint in ITP, demonstrating statistically significant improvement in time to treatment failure - GlobeNewsWire
- 16 days ago - Roche, Novartis due to meet Swiss govt. amid Trump’s tariff threats: Reuters - Seeking Alpha